CCC - Primary Care Flashcards
Asthma - Management
1) Salbutamol
2) ICS (200mg)
3) LABA
- benefit = continue
- some benefit, continue and increase ICS to 800mg
- no benefit - stop, increase ICS, trial LTRA
4) ICS to 2000
5) Oral prednisolone
- Refer
Asthma Review
- Smoking cessation
- Inhaler technique
- Symptom control (compliance)
- Admissions
- Exacerbations
- Flu jab and PCV
- Mood
Acute AF - Unstable
DC Cardioversion
Medical cardioversion: Amiodarone
Acute AF - Stable
Rate control:
- Bisoprolol 2.5mg
- Verapamil 40-120mg/8 hours
Anticoagulation with LMWH
Chronic AF - Rate control
Beta blocker
- Atenolol
- Not in asthma
Rate limiting calcium channel blocker
- Verapamil/diltazem
- Not in HF
Digoxin
- Only if sedentary life style
Chronic AF - Rhythm Control
ECHO
- No structural abnormality - flecainide
- Structural abnormality - amiodarone
- Surgical ablation
Stable Angina - 1st Line
Beta blocker - Bisoprolol 2.5mg OR Rate limiting Calcium channel blocker - Diltiazem/verapamil
Long Acting mononitrate
- Isosorbide mononitrate
- May become tolerant
GTN Spray/sublingual tablet
- Symptom relief
Stable Angina - Secondary Prevention
- Aspirin 75mg
- ACEi if diabetic
- Statin/hypertensive
Revascularisation
- CABG
- PCI (single vessel disease)
Stable Angina - Review
6 months - 1 year
- Symptoms (rest, exercise, duration)
- CVD risk
- Modifiable risk factors
- Medication r/v
SCREEN: Heart failure and depression
Q RISK 2 - Who?
Assess every 5 years
- > 40 years
- First degree relative with premature CVD or familial hyperlipidaemia
CVD - Modifiable risk factors
- Diet
- Smoking
- Stress
- Exercise
- Alcohol
CVD - Primary Prevention
> 10% in 10 years
- Atorvastatin 20mg
BP
- ACEi if diabetic
- Follow ACD rule
CHA2DS2VASC
Congestive heart failure Hypertension Age >75 (2) 65-74 (1) Diabetes Stroke/TIA/VTE Vascular disease (MI, angina, peripheral vasc. disease) Sex (Female = 1)
ANTICOAGULATE
- Men @ 1+
- Women @ 2+
HASBLED
Hypertension >160 Abnormal renal (1), liver (1) Stroke Bleeding history Labile INR Elderly (>65) Drugs - Alcohol (8U/week) - NSAIDs/anti platelet
COPD - FEV >50% (mild-mod)
SABA,
SABA + LABA,
Combohaler (ICS/LABA) + LAMA
OR
SAMA
LAMA
COMBOHALER + LAMA
COPD - FEV <50% (severe)
SABA
SABA + COMBOHALER
COMBO-HALER + LAMA
or
SAMA
LAMA
COMBOHALER + LAMA
COPD - Extra Management
STOP SMOKING!!
Rescue Pack
- Prednisolone 30mg 7 days
- Amoxicillin 500mg 5 days
COPD - Review
6M (severe), 1Y (mild-mod)
- Mood
- Smoking cessation
- Inhaler Technique
- O2 sats, BMI
- Medication
- Exacerbations, admissions
- Flu jab/PCV
CKD - Stages
1) >90 (normal)
2) 60-89
3a) 45-59
3b) 30-44
4) 15-29
5) <15
CKD - Stage 1-2 Management
- Annual monitoring
- ACEi
- CV risk
CKD - Stage 3a and 3b Management
- CVS Risk
- Investigate proteinuria, haematuria, declining eGFR, young age
- Decrease use of nephrotoxic drugs
CKD - Stage 4 Management
- Urgent referral
- Medication review if eGFR <30
Diabetes - Education
- Vaccinations
- Exercise (increase insulin sensitivity)
- Smoking cessation
- Work (if on insulin, no army, machinery, driving)
- Diet